Advances in the knowledge of gastric cancer, including the role of the HER2 pathway, the characterization of its molecular development, and a deeper understanding of the tumor microenvironment, have raised new hypotheses to improve new therapeutic strategies, including immunotherapy. Here, ERBB2 is linked to neoplasm.